318 related articles for article (PubMed ID: 23703334)
21. Interplay of vitamin D and metabolic syndrome: A review.
Prasad P; Kochhar A
Diabetes Metab Syndr; 2016; 10(2):105-12. PubMed ID: 25813139
[TBL] [Abstract][Full Text] [Related]
22. Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration.
Morrison MA; Silveira AC; Huynh N; Jun G; Smith SE; Zacharaki F; Sato H; Loomis S; Andreoli MT; Adams SM; Radeke MJ; Jelcick AS; Yuan Y; Tsiloulis AN; Chatzoulis DZ; Silvestri G; Kotoula MG; Tsironi EE; Hollis BW; Chen R; Haider NB; Miller JW; Farrer LA; Hageman GS; Kim IK; Schaumberg DA; DeAngelis MM
Hum Genomics; 2011 Oct; 5(6):538-68. PubMed ID: 22155603
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
24. Is there an association between vitamin D and hypertension?
Cosenso-Martin LN; Vilela-Martin JF
Recent Pat Cardiovasc Drug Discov; 2011 May; 6(2):140-7. PubMed ID: 21513491
[TBL] [Abstract][Full Text] [Related]
25. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
26. Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D.
Carrara D; Bruno RM; Bacca A; Taddei S; Duranti E; Ghiadoni L; Bernini G
J Hypertens; 2016 Nov; 34(11):2199-205. PubMed ID: 27648718
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?
Lee JH; O'Keefe JH; Bell D; Hensrud DD; Holick MF
J Am Coll Cardiol; 2008 Dec; 52(24):1949-56. PubMed ID: 19055985
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D and Cardiovascular Disease.
Wang TJ
Annu Rev Med; 2016; 67():261-72. PubMed ID: 26768241
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D and cardiovascular disease prevention.
Pilz S; Verheyen N; Grübler MR; Tomaschitz A; März W
Nat Rev Cardiol; 2016 Jul; 13(7):404-17. PubMed ID: 27150190
[TBL] [Abstract][Full Text] [Related]
30. [Vitamin D and hypertension].
Moyano Peregrín C; López Rodríguez F; Castilla Castellano Mdel M
Med Clin (Barc); 2012 Apr; 138(9):397-401. PubMed ID: 21703643
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D and cardiovascular disorders.
Bouillon R
Osteoporos Int; 2019 Nov; 30(11):2167-2181. PubMed ID: 31402402
[TBL] [Abstract][Full Text] [Related]
32. Are vitamin D deficiency and VDR gene polymorphisms associated with high blood pressure as defined by the ACC/AHA 2017 criteria in postmenopausal women?
Santos BR; Casanova G; Silva TR; Marchesan LB; Oppermann K; Spritzer PM
Maturitas; 2021 Jul; 149():26-33. PubMed ID: 34134887
[TBL] [Abstract][Full Text] [Related]
33. Should hypertensive patients take vitamin D?
Wuerzner G; Burnier M; Waeber B
Curr Hypertens Rep; 2012 Aug; 14(4):318-23. PubMed ID: 22648128
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D and Cardiovascular Disease: Controversy Unresolved.
Al Mheid I; Quyyumi AA
J Am Coll Cardiol; 2017 Jul; 70(1):89-100. PubMed ID: 28662812
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure.
Li YC; Qiao G; Uskokovic M; Xiang W; Zheng W; Kong J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):387-92. PubMed ID: 15225806
[TBL] [Abstract][Full Text] [Related]
36. Health outcomes of vitamin D. Part II. Role in prevention of diseases.
Wranicz J; Szostak-Węgierek D
Rocz Panstw Zakl Hig; 2014; 65(4):273-9. PubMed ID: 25526571
[TBL] [Abstract][Full Text] [Related]
37. [Genetic aspects in pathogenesis and optimization of arterial hypertension pharmacotherapy].
Milotova NM; Shikh EV
Antibiot Khimioter; 2008; 53(5-6):42-50. PubMed ID: 19069182
[No Abstract] [Full Text] [Related]
38. Impaired vitamin D sensitivity.
Máčová L; Bičíková M; Hampl R
Physiol Res; 2018 Nov; 67(Suppl 3):S391-S400. PubMed ID: 30484666
[TBL] [Abstract][Full Text] [Related]
39. Nocturnal diastolic blood pressure decline is associated with higher 25-hydroxyvitamin D level and standing plasma renin activity in a hypertensive population.
Zhang M; Xu X; Liu H; Li H; Zhang J; Gao M
Clin Exp Hypertens; 2017; 39(8):685-690. PubMed ID: 28872358
[TBL] [Abstract][Full Text] [Related]
40. Non-musculoskeletal benefits of vitamin D.
Wimalawansa SJ
J Steroid Biochem Mol Biol; 2018 Jan; 175():60-81. PubMed ID: 27662817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
